Officinalisinin I

CAS No. 57944-18-0

Officinalisinin I( —— )

Catalog No. M18844 CAS No. 57944-18-0

Officinalisinin I can effectively reduce the blood glucose and protect nerve injuryin diabetic mice.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 133 In Stock
5MG 86 In Stock
10MG 122 In Stock
25MG 204 In Stock
50MG 296 In Stock
100MG 436 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Officinalisinin I
  • Note
    Research use only, not for human use.
  • Brief Description
    Officinalisinin I can effectively reduce the blood glucose and protect nerve injuryin diabetic mice.
  • Description
    Officinalisinin I can effectively reduce the blood glucose and protect nerve injuryin diabetic mice.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    ERK
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    57944-18-0
  • Formula Weight
    921.07
  • Molecular Formula
    C45H76O19
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (108.57 mM)
  • SMILES
    C[C@H]1[C@H]2[C@H](C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC[C@H]5[C@@]4(CC[C@@H](C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C)C)OC1(CC[C@H](C)CO[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Liu J, et al. Study on hypoglycemic mechanism and central nerve protection of Officinalisinin I in Rhizoma Anemarrhenae[J]. China Journal of Traditional Chinese Medicine & Pharmacy, 2017.
molnova catalog
related products
  • LY-3214996

    LY-3214996 is a novel potent, selective, orally active ERK1/2 inhibitor with IC50 of 5 nM for both enzymes in biochemical assays.

  • Ulixertinib hydrochl...

    Ulixertinib hydrochloride (Ulixertinib HCl) is an orally available, selective and potent ERK1/2 inhibitor with anticancer and antitumor activity that inhibits the NB cell cycle and promotes apoptosis, and may be used in the study of solid tumors.

  • MK-8353 hydrochlorid...

    MK-8353 hydrochloride (SCH-900353) is a highly potent, orally bioavailable, dual-specificity ERK1/2 inhibitor with IC50 of 23.0/8.8 nM, respectively.